Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients

被引：15

作者：

Castagna, M. G. ^{[1
]}

Cantara, S. ^{[1
]}

Pacini, F. ^{[1
]}

机构：

[1] Univ Siena, Dept Med Surg & Neurol Sci, Viale Bracci 1, I-53100 Siena, Italy

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 2016年 / 39卷 / 10期

关键词：

Radioiodine; Thyroid ablation; Thyroid; cancer; Thyroglobulin; rhTSH; RECOMBINANT HUMAN TSH; RADIOACTIVE IODINE THERAPY; SERUM THYROGLOBULIN-LEVEL; DISEASE-FREE STATUS; LOW-RISK PATIENTS; REMNANT ABLATION; STIMULATED THYROGLOBULIN; HUMAN THYROTROPIN; PROGNOSTIC VALUE; UNDETECTABLE THYROGLOBULIN;

D O I：

10.1007/s40618-016-0503-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Radioactive iodine therapy is administered to patients with differentiated thyroid cancer (DTC) for eradication of thyroid remnant after total thyroidectomy or, in patients with metastatic disease, for curative or palliative treatment. In past years, thyroid remnant ablation was indicated in almost every patient with a diagnosis of DTC. Nowadays, careful revision of patients' outcome has introduced the concept of risk-based selection of patients candidate to thyroid remnant ablation. The present review aims to underline the indications for thyroid remnant ablation and to address methodologies to be employed.

引用

页码：1087 / 1094

页数：8

共 50 条

[1] Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients
M. G. Castagna
S. Cantara
F. Pacini
[J]. Journal of Endocrinological Investigation, 2016, 39 : 1087 - 1094
[2] Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients
Verburg, FA
de Keizer, B
Lips, CJM
Zelissen, PMJ
de Klerk, JMH
[J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (01) : 33 - 37
[3] Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything?
R. Forleo
N. Fralassi
F. Maino
M. Capezzone
L. Brilli
T. Pilli
S. Cantara
M. G. Castagna
[J]. Journal of Endocrinological Investigation, 2021, 44 : 139 - 144
[4] Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything?
Forleo, R.
Fralassi, N.
Maino, F.
Capezzone, M.
Brilli, L.
Pilli, T.
Cantara, S.
Castagna, M. G.
[J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (01) : 139 - 144
[5] Is ablation with radioiodine an alternative to completion thyroidectomy in large thyroid remnants in selected patients with differentiated thyroid cancer?
Costa, G.
Azevedo-Silva, F.
Vieira, F.
Albuquerque, A.
Pedroso-Lima, J.
Ferrer-Antunes, A. I.
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S230 - S230
[6] Different Radioiodine Dose for Remnant Thyroid Ablation in Patients With Differentiated Thyroid Cancer A Meta-analysis
Song, Xinghua
Meng, Zhaowei
Jia, Qiang
Zhang, Linlin
Xu, Ke
Tan, Jian
Zhang, Guizhi
Zheng, Wei
Li, Xue
Zhang, Jianping
[J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (10) : 774 - 779
[7] Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer
Bal, CS
Kumar, A
Pant, GS
[J]. NUCLEAR MEDICINE COMMUNICATIONS, 2003, 24 (02) : 203 - 208
[8] Quality of Life Survey Following Radioiodine Ablation in Patients with Differentiated Thyroid Cancer
Nikoleta Gkatzia
Angelos Papadopoulos
Petros Kostagiolas
Theodoros Karianos
Sofia Saranti
[J]. SN Comprehensive Clinical Medicine, 2021, 3 (1) : 158 - 165
[9] Radioiodine in differentiated thyroid cancer
Borner, AR
MullerGartner, HW
[J]. ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (04): : 274 - 285
[10] The calculation of the ablation activities for radioiodine therapy of differentiated thyroid cancer with provision for thyroid stunning
Dzhuzha, DA
[J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S467 - S467

← 1 2 3 4 5 →